Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shant Shirvanian & Victor F. Tapson. (2015) Venous thromboembolism: identifying patients at risk and establishing prophylaxis. Current Medical Research and Opinion 31:12, pages 2297-2311.
Read now
Read now
Frank Akwaa & Alex C. Spyropoulos. (2014) The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism. Current Medical Research and Opinion 30:11, pages 2179-2190.
Read now
Read now
Articles from other publishers (9)
Jeffrey S. Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune, Yongling Xiao, Jeff Schein, Patrick Lefebvre & Scott Kaatz. (2018) Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism. Research and Practice in Thrombosis and Haemostasis 2:1, pages 58-68.
Crossref
Crossref
Alok A. Khorana, Jeffrey S. Berger, Philip S. Wells, Roger Seheult, Veronica Ashton, François Laliberté, Concetta Crivera, Dominique Lejeune, Jeff Schein, Peter Wildgoose, Patrick Lefebvre & Scott Kaatz. (2017) Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE. Clinical Therapeutics 39:7, pages 1396-1408.
Crossref
Crossref
Jingfu Liu, Na Wang, Yujuan Chen, Rong Lu & Xianren Ye. (2017) Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. Journal of Obstetrics and Gynaecology Research 43:1, pages 202-210.
Crossref
Crossref
Alpesh Amin & Joel C. Marrs. (2016) Direct Oral Anticoagulants for the Management of Thromboembolic Disorders. Clinical and Applied Thrombosis/Hemostasis 22:7, pages 605-616.
Crossref
Crossref
Sin Hyung Park, Joong Hyeon Ahn, Yong Bok Park, Sun Geun Lee & Soo Jae Yim. (2016) Incidences of Deep Vein Thrombosis and Pulmonary Embolism after Total Knee Arthroplasty Using a Mechanical Compression Device with and without Low-Molecular-Weight Heparin. Knee Surgery & Related Research 28:3, pages 213-218.
Crossref
Crossref
C. Rubio-Terrés, J. M. Soria, P. E. Morange, J. C. Souto, P. Suchon, J. Mateo, N. Saut, D. Rubio-Rodríguez, J. Sala, A. Gracia, S. Pich & E. Salas. (2015) Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism. Applied Health Economics and Health Policy 13:2, pages 233-242.
Crossref
Crossref
Joyce C. LaMori, Omar Shoheiber, Samir H. Mody & Brahim K. Bookhart. (2015) Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States. Clinical Therapeutics 37:1, pages 62-70.
Crossref
Crossref
Rupert Bauersachs. (2014) Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders. Clinical Investigation 4:7, pages 619-639.
Crossref
Crossref
Hiroshi Sasaki, Kazunari Ishida, Nao Shibanuma, Katsumasa Tei, Hiroomi Tateishi, Akihiko Toda, Yukiko Yamashiro, Tomoyuki Matsumoto, Ryosuke Kuroda & Masahiro Kurosaka. (2013) Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty. International Orthopaedics 38:3, pages 525-529.
Crossref
Crossref